Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-06-008421
Filing Date
2006-02-13
Accepted
2006-02-13 17:03:47
Documents
1
Group Members
CITADEL DERIVATIVES GROUP LLCCITADEL EQUITY FUND LTD.CITADEL INVESTMENT GROUP, L.L.C.CITADEL KENSINGTON GLOBAL STRATEGIES FUND LTD.CITADEL TRADING GROUP L.L.C.CITADEL WELLINGTON LLCKENNETH GRIFFIN

Document Format Files

Seq Description Document Type Size
1 AMENDMENT a06-4579_15sc13ga.htm SC 13G/A 280489
  Complete submission text file 0001104659-06-008421.txt   282762
Mailing Address 34801 CAMPUS DR FREMONT CA 94555
Business Address 34801 CAMPUS DR FREMONT CA 94555 5105741400
PDL BIOPHARMA, INC. (Subject) CIK: 0000882104 (see all company filings)

EIN.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-43256 | Film No.: 06604597
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 131 S. DEARBORN STREET, 32ND FLOOR CHICAGO IL 60603
Business Address 131 S. DEARBORN STREET, 32ND FLOOR CHICAGO IL 60606 3123952100
CITADEL L P (Filed by) CIK: 0001027745 (see all company filings)

EIN.: 364111741 | State of Incorp.: IL | Fiscal Year End: 1231
Type: SC 13G/A